The Pennant Group (NASDAQ:PNTG) Rating Reiterated by Stephens

The Pennant Group (NASDAQ:PNTGGet Free Report)‘s stock had its “overweight” rating reaffirmed by equities researchers at Stephens in a note issued to investors on Thursday, Benzinga reports. They currently have a $25.00 target price on the stock. Stephens’ price target points to a potential upside of 11.01% from the company’s previous close.

A number of other equities analysts also recently commented on the stock. Oppenheimer boosted their price objective on shares of The Pennant Group from $18.00 to $22.00 and gave the stock an “outperform” rating in a research note on Friday, March 1st. Royal Bank of Canada boosted their price objective on shares of The Pennant Group from $21.00 to $26.00 and gave the stock an “outperform” rating in a research note on Thursday, May 9th. Finally, Truist Financial boosted their price objective on shares of The Pennant Group from $22.00 to $25.00 and gave the stock a “hold” rating in a research note on Wednesday, May 15th.

Check Out Our Latest Report on The Pennant Group

The Pennant Group Stock Up 2.2 %

Shares of NASDAQ:PNTG opened at $22.52 on Thursday. The Pennant Group has a 1 year low of $10.31 and a 1 year high of $24.09. The business has a 50 day simple moving average of $22.20 and a two-hundred day simple moving average of $18.53. The firm has a market capitalization of $676.73 million, a PE ratio of 41.70, a price-to-earnings-growth ratio of 2.40 and a beta of 2.02. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.16 and a quick ratio of 1.16.

The Pennant Group (NASDAQ:PNTGGet Free Report) last posted its quarterly earnings results on Monday, May 6th. The company reported $0.15 earnings per share for the quarter, meeting the consensus estimate of $0.15. The Pennant Group had a net margin of 2.86% and a return on equity of 13.42%. The firm had revenue of $156.92 million during the quarter, compared to the consensus estimate of $146.01 million. On average, equities analysts predict that The Pennant Group will post 0.73 EPS for the current year.

Hedge Funds Weigh In On The Pennant Group

Institutional investors and hedge funds have recently bought and sold shares of the company. Covestor Ltd grew its holdings in The Pennant Group by 3,805.6% in the first quarter. Covestor Ltd now owns 1,406 shares of the company’s stock worth $28,000 after purchasing an additional 1,370 shares during the last quarter. AJOVista LLC purchased a new stake in shares of The Pennant Group during the fourth quarter valued at $35,000. DekaBank Deutsche Girozentrale purchased a new stake in shares of The Pennant Group during the fourth quarter valued at $52,000. SG Americas Securities LLC purchased a new stake in shares of The Pennant Group during the fourth quarter valued at $107,000. Finally, Mackenzie Financial Corp purchased a new stake in shares of The Pennant Group during the fourth quarter valued at $155,000. 85.88% of the stock is owned by hedge funds and other institutional investors.

The Pennant Group Company Profile

(Get Free Report)

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.

Featured Articles

Receive News & Ratings for The Pennant Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for The Pennant Group and related companies with MarketBeat.com's FREE daily email newsletter.